Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

INTRODUCTION: We aimed to compare the efficacy of insulin degludec/insulin aspart (IDegAsp) and insulin degludec/liraglutide (IDegLira) in controlling glucose fluctuation and suppressing postprandial glucose levels using intermittently scanned continuous glucose monitoring. METHODS: Twenty-four pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yuji, Miyamoto, Shoko, Hajika, Yuriko, Ashida, Narumi, Hirota, Tomoe, Masumoto, Koji, Sawa, Jun, Hamazaki, Kenji, Kumeda, Yasuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122848/
https://www.ncbi.nlm.nih.gov/pubmed/35403949
http://dx.doi.org/10.1007/s12325-022-02138-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122848/
https://www.ncbi.nlm.nih.gov/pubmed/35403949
http://dx.doi.org/10.1007/s12325-022-02138-w

Ejemplares similares